132 related articles for article (PubMed ID: 24720773)
21. PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Alfonso F; Sabaté M; Fernández C; Stranieri C; Trabetti E; Pignatti PF; Macaya C
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):89-93. PubMed ID: 15166949
[TBL] [Abstract][Full Text] [Related]
22. Aspirin resistance in cerebrovascular disease and the role of glycoprotein IIIa polymorphism in Turkish stroke patients.
Derle E; Öcal R; Kibaroğlu S; Çelikkol C; Bayraktar N; Verdi H; Ataç BF; Can U
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):169-75. PubMed ID: 26809135
[TBL] [Abstract][Full Text] [Related]
23. Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis.
Wang J; Liu J; Zhou Y; Wang F; Xu K; Kong D; Bai J; Chen J; Gong X; Meng H; Li C
Sci Rep; 2019 Sep; 9(1):13177. PubMed ID: 31511539
[TBL] [Abstract][Full Text] [Related]
24. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
Gao F; Wang ZX; Men JL; Ren J; Wei MX
Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
[TBL] [Abstract][Full Text] [Related]
25. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
Chen CH; Lo YK; Ke D; Liu CK; Liou CW; Wu HL; Lai ML;
J Neurol Sci; 2004 Dec; 227(1):1-5. PubMed ID: 15546585
[TBL] [Abstract][Full Text] [Related]
26. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
Anderson JL; King GJ; Bair TL; Elmer SP; Muhlestein JB; Habashi J; Carlquist JF
J Am Coll Cardiol; 1999 Mar; 33(3):727-33. PubMed ID: 10080474
[TBL] [Abstract][Full Text] [Related]
27. The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis.
Renner W; Winkler M; Hoffmann C; Köppel H; Seinost G; Brodmann M; Pilger E
Int Angiol; 2001 Jun; 20(2):148-51. PubMed ID: 11533523
[TBL] [Abstract][Full Text] [Related]
28. Integrin beta3 Leu33Pro homozygosity and risk of cancer.
Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
J Natl Cancer Inst; 2003 Aug; 95(15):1150-7. PubMed ID: 12902444
[TBL] [Abstract][Full Text] [Related]
29. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation.
Boudoulas KD; Cooke GE; Roos CM; Bray PF; Goldschmidt-Clermont PJ
Arch Pathol Lab Med; 2001 Jan; 125(1):112-5. PubMed ID: 11151063
[TBL] [Abstract][Full Text] [Related]
30. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
[TBL] [Abstract][Full Text] [Related]
31. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
Addad F; Elalamy I; Chakroun T; Abderrazek F; Dridi Z; Hamdi S; Hassine M; Ben-Farhat M; Gerotziafas G; Hatmi M; Gamra H
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):674-8. PubMed ID: 20739877
[TBL] [Abstract][Full Text] [Related]
32. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
[TBL] [Abstract][Full Text] [Related]
33. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
Li Q; Chen BL; Ozdemir V; Ji W; Mao YM; Wang LC; Lei HP; Fan L; Zhang W; Liu J; Zhou HH
Pharmacogenomics; 2007 Jun; 8(6):577-86. PubMed ID: 17559347
[TBL] [Abstract][Full Text] [Related]
34. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
[TBL] [Abstract][Full Text] [Related]
35. Dose-related efficacy of aspirin after coronary surgery in patients With Pl(A2) polymorphism (NCT00262275).
Lim E; Carballo S; Cornelissen J; Ali ZA; Grignani R; Bellm S; Large S
Ann Thorac Surg; 2007 Jan; 83(1):134-8. PubMed ID: 17184645
[TBL] [Abstract][Full Text] [Related]
36. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.
Ridker PM; Hennekens CH; Schmitz C; Stampfer MJ; Lindpaintner K
Lancet; 1997 Feb; 349(9049):385-8. PubMed ID: 9033464
[TBL] [Abstract][Full Text] [Related]
37. Impact of genetic polymorphisms on platelet function and aspirin resistance.
Pamukcu B; Oflaz H; Onur I; Hancer V; Yavuz S; Nisanci Y
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):53-6. PubMed ID: 19923980
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.
Dropinski J; Musial J; Sanak M; Wegrzyn W; Nizankowski R; Szczeklik A
Thromb Res; 2007; 119(3):301-3. PubMed ID: 16675000
[TBL] [Abstract][Full Text] [Related]
39. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
40. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
Mikkelsson J; Perola M; Laippala P; Penttilä A; Karhunen PJ
J Am Coll Cardiol; 2000 Oct; 36(4):1317-23. PubMed ID: 11028489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
